Cite
Cladribine tablets after treatment with natalizumab (CLADRINA) – rationale and design
MLA
Peter V. Sguigna, et al. “Cladribine Tablets after Treatment with Natalizumab (CLADRINA) – Rationale and Design.” Therapeutic Advances in Neurological Disorders, vol. 17, Apr. 2024. EBSCOhost, https://doi.org/10.1177/17562864241233858.
APA
Peter V. Sguigna, Rehana Z. Hussain, Annette Okai, Kyle M. Blackburn, Lauren Tardo, Mariam Madinawala, Julie Korich, Lori A. Lebson, Jeffrey Kaplan, Amber Salter, Navid Manouchehri, & Olaf Stuve. (2024). Cladribine tablets after treatment with natalizumab (CLADRINA) – rationale and design. Therapeutic Advances in Neurological Disorders, 17. https://doi.org/10.1177/17562864241233858
Chicago
Peter V. Sguigna, Rehana Z. Hussain, Annette Okai, Kyle M. Blackburn, Lauren Tardo, Mariam Madinawala, Julie Korich, et al. 2024. “Cladribine Tablets after Treatment with Natalizumab (CLADRINA) – Rationale and Design.” Therapeutic Advances in Neurological Disorders 17 (April). doi:10.1177/17562864241233858.